ATOM

Sponsor: University of Oxford

ClinicalTrials.gov Number: NCT02628080

 

Atovaquone as Tumour HypOxia Modifier

Full title: Pre-operative window of opportunity study of the effects of atovaquone on hypoxia in non-small cell lung carcinoma

 

STUDY DESIGN

Open label window of opportunity study

STUDY POPULATION

Patients with suspected non-small cell lung cancer (NSCLC)

I'd like to Know More

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Prestigious Royal College of Radiologists 2014 Gold Medal Awarded to Professor Gillies McKenna

Professor Gillies McKenna has been awarded the 2014 Gold Medal from The Royal College of Radiologists.  The medal is the highest honour the College has to bestow, and was awarded to Gillies for his ‘enormous national and international contribution to clinical oncology research and training.’

MErCuRIC study launched

Professor Tim Maughan from the Gray Institute for Radiation Oncology and Biology, University of Oxford is working on a new collaboration with the Queen’s University in Belfast who are leading a euro-wide research programme to find a new treatment for bowel cancer. This new research is being funded by the European Commission.

The MErCuRIC study, which was launched yesterday in Belfast, involves eight different countries and will look at two major genetic factors which make bowel cancer difficult to treat.

Pages

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to Department of Oncology RSS